Skip to main content Skip to main navigation menu Skip to site footer
Review
Published: 2021-11-21

Medical nutrition therapeutic approach of non-alcoholic fatty liver: diet, nutraceuticals, phytotherapy and probiotics

FUNCAMP - Unicamp Development Foundation, Campinas, Sao Paulo, Brazil
ABRAN - Associação Brasileira de Nutrologia / Brazilian Association of Nutrology, Catanduva, Sao Paulo, Brazil
Liver steatosis Therapy NAFLD Phytotherapy Probiotics

Abstract

Although the genetic and pharmacological research of the non-alcoholic fatty liver disease (NAFLD), the commonest liver disease in the world, affecting more than a quarter of the population, shows a promising future, the non-pharmacological therapy continues to be an important approach of this concerning public health issue. The present study focused on the therapeutical potential of the diet and mainly the phytotherapy, nutraceuticals, and probiotics use, employing the literature review methodology by a selection of recent (last 5-10 years) national and international articles from the PubMed and Google Scholar databases. The conclusion was that the non-pharmacological medical nutrition approach could be considered as a first-line therapeutical option for NAFLD due to its low cost, few adverse effects, and a mainly positive impact on an individual's health and life quality.

References

  1. Ferro D, Baratta F, Pastori D, Cocomello N, Colantoni A, Angelico F, Del Ben M. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Nutrients. 2020 Sep 10;12(9):2762. doi: 10.3390/nu12092762. PMID: 32927776; PMCID: PMC7551294.
  2. Abenavoli L, Scarpellini E, Pellicano R, Fagoonee S, Larussa T, Luzza F. Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease. Minerva Med. 2020 Dec;111(6):526-528. doi: 10.23736/S0026-4806.20.07089-5. Epub 2020 Nov 3. PMID: 33140925.
  3. Pérez-Montes de Oca A, Julián MT, Ramos A, Puig-Domingo M, Alonso N. Microbiota, Fiber, and NAFLD: Is There Any Connection? Nutrients. 2020 Oct 12;12(10):3100. doi: 10.3390/nu12103100. PMID: 33053631; PMCID: PMC7600472.
  4. Stefan N, Haring H, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. The Lancet Diabetes & Endocrinology. 2018; 7(4): p. 313- 324.
  5. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non alcoholic fatty liver disease(NAFLD). Metabolism. 2016; 65(8): p. 1038-48.
  6. Tana C, Ballestri S, Ricci F et al. Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. Int J Environ Res Public Health. 2019; 16(17): p. 3104.
  7. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n71 .
  8. H Balshem H, Grade guidelines: 3 ratng the quality of evidence. Journal of Clinical Epidemiology, Maryland Heights, 64 (4) (2011) 401-406.
  9. Higgins, S Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011.
  10. Khan RS, Bril F, Cusi K, Newsome PN. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. Hepatology. 2019 Jul; 70(2): p. 711-724.
  11. Wehmeyer MH ZBJBREWESZWJea. Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern. Medicine(Baltimore). 2016 Jun; 95(23).
  12. Barrera F, George J. Review The role of diet and nutritional intervention for the management of patients with NAFLD. Clin Liver Dis. 2014 Feb; 18(1):91-112.
  13. Eslamparast T, Tandon P, Raman M. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Nutrients. 2017 Jul; 9(8): p. 800.
  14. Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin. Nutr. 2014; 33: p. 678–683.
  15. Biolato M, Manca F, Marrone G, et al. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. World J Gastroenterol. 2019;25(4):509–520.
  16. De Castro GS, Calder PC. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clin. Nutr. 2018 Feb;37(1):37-55.
  17. Zhang S, Fu J, Zhang Q, Liu L, Meng G, Yao Z et al. Association between nut consumption and non- alcoholic fatty liver disease in adultsLiver Int. 2019 Sep;39(9):1732-1741.
  18. Antonucci L, Porcu C, Iannucci G, Balsano B, Barbaro B. Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper. Nutrients. 2017 Oct; 9(10): 1137.
  19. Siddique A, Nelson JE, Aouizerat B, Yeh MM, Kowdley KV. Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin.Clin Gastroenterol Hepatol. 2014 Jul;12(7):1170-1178.
  20. Mitchell T, McKinnon E, Ayonrinde O, Adams LA, Trinder D, Chua ACG et al. Decreased Physical Working Capacity in Adolescents With Nonalcoholic Fatty Liver Disease Associates With Reduced Iron Availability. Clin Gastroenterol Hepatol. 2019 Oct; (19): 31116-4.
  21. European Association for the Study of the Liver (EASL) European Association for the Study of Diabetes (EASD) European Association for the Study of Obesity (EASO) EASL-EASD-EASO. Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 2016;64:1388– 1402.
  22. Yang Z, Wu J, Li X, Xie D, Wang Y, Yang T. Association between dietary iron intake and the prevalence of nonalcoholic fatty liver disease: A cross-sectional study. Medicine (Baltimore). 2019 Oct;98(43):e17613.
  23. Vincent JB. Effects of chromium supplementation on body composition, human and animal health, and insulin and glucose metabolism. Curr Opin Clin Nutr Metab Care. 2019 Nov;22(6):483-489.
  24. Saab S1, Mallam D, Cox GA 2nd, Tong MJ.Impact of coffee on liver diseases: a systematic review. Liver Int. 2014 Apr;34(4):495-504.
  25. Hajifathalian K, Torabi Sagvand B, McCullough AJ. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study. Hepatology. 2019 Aug;70(2):511-521. Epub 2018 Oct 2.
  26. Zhou J, Ho CT, Long P, Meng Q, Zhang L, Wan X. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. J Agric Food Chem. 2019 May 15;67(19):5306- 5317.
  27. Bae M, Park YK, Lee JY. Food components with antifibrotic activity and implications in prevention of liver disease. J Nutr Biochem. 2018;55:1–11.
  28. Kessoku T, Imajo K, Honda Y, Kato T, Ogawa Y, Tomeno W et al. Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis. Sci Rep. 2016 Feb 25; 6():22251.
  29. Kim M, Yang SG, Kim JM, Lee JW, Kim YS, Lee JISilymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Int J Mol Med. 2012 Sep; 30(3):473-9.
  30. Wei J, Lei GH, Fu L, Zeng C, Yang T, Peng SF. Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.PLoS One. 2016 Jan 29;11(1):e0147985.
  31. Zhang Z, Thorne JL, Moore JB. Vitamin D and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2019 Nov;22(6):449-458.
  32. Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo‐Perez F, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63:764‐775.
  33. Jing Y, Chen C, Jing HC, Jian XW, Rui FY, Diu L et al. Fatty liver disease caused by high-alcohol- producing Klebsiella pneumoniae. Cell Metab Clin and Transl Rep. 2019; 30 (04):675-88.
  34. Khan RS, Bril F, Cusi K, Newsome P N. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. Hepatology. 2019;70: 711-724.
  35. Loman BR, Hernandez-Saavedra D, An R, Rector RS. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutr Rev. 2018;76(11):822–39.
  36. Behrouz V, Aryaeian N, Zahedi MJ, Jazayeri S. Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial. J Food Sci. 2020 Oct;85(10):3611-3617. doi: 10.1111/1750-3841.15367. Epub 2020 Sep 4. PMID: 32885440.

How to Cite

Oprea, C., & Ribas Filho, . D. (2021). Medical nutrition therapeutic approach of non-alcoholic fatty liver: diet, nutraceuticals, phytotherapy and probiotics. International Journal of Nutrology, 14(4). https://doi.org/10.54448/ijn21401